NCT02970370

Brief Summary

The primary study aim is to depict the demographics, clinical and para clinical features of patients attending five tertiary referral multiple sclerosis (MS) centers in Egypt. This requires effective and unified pooled registries to extract data from with a standardized, sufficient and high quality clinical, magnetic resonance imaging (MRI) data, neurophysiological data and body fluids. Investigators want to shed light on the challenges that face both physicians and patients in the area of "diagnosis and treatment"

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,752

participants targeted

Target at P75+ for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2015

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2016

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

November 18, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 22, 2016

Completed
Last Updated

November 22, 2016

Status Verified

November 1, 2016

Enrollment Period

7 months

First QC Date

November 18, 2016

Last Update Submit

November 21, 2016

Conditions

Multiple Sclerosis

Outcome Measures

Primary Outcomes (1)

  • portrayed phenotypes and para-clinical data of Egyptian Multiple Sclerosis Patients

    6 months

Interventions

no interventionOTHER

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Radiologically isolated syndrome, Clinically isolated Syndrome , Multiple Sclerosis, Neuromyelitis optica spectrum disorders (NMOSD), MS mimics

You may qualify if:

  • Patients with MS/NMOSD or their mimics who sought advice in one of our centers even once

You may not qualify if:

  • Patients with missing data in their records that couldn't be completed

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Target Duration
15 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Neurology

Study Record Dates

First Submitted

November 18, 2016

First Posted

November 22, 2016

Study Start

December 1, 2015

Primary Completion

July 1, 2016

Last Updated

November 22, 2016

Record last verified: 2016-11